S&P 500   4,122.47 (-0.42%)
DOW   32,774.41 (-0.18%)
QQQ   317.08 (-1.13%)
AAPL   164.92 (+0.03%)
MSFT   282.30 (+0.71%)
META   168.53 (-1.01%)
GOOGL   116.63 (-0.57%)
AMZN   137.83 (-1.13%)
TSLA   850.00 (-2.44%)
NVDA   170.86 (-3.97%)
NIO   19.17 (-4.96%)
BABA   91.19 (+0.39%)
AMD   95.54 (-4.53%)
MU   59.15 (-3.74%)
T   18.10 (+0.56%)
CGC   2.87 (-12.50%)
GE   74.93 (-0.33%)
F   15.19 (-3.74%)
DIS   108.13 (-0.90%)
AMC   22.45 (-6.30%)
PYPL   94.48 (-1.85%)
PFE   49.78 (+0.42%)
NFLX   229.94 (-1.52%)
S&P 500   4,122.47 (-0.42%)
DOW   32,774.41 (-0.18%)
QQQ   317.08 (-1.13%)
AAPL   164.92 (+0.03%)
MSFT   282.30 (+0.71%)
META   168.53 (-1.01%)
GOOGL   116.63 (-0.57%)
AMZN   137.83 (-1.13%)
TSLA   850.00 (-2.44%)
NVDA   170.86 (-3.97%)
NIO   19.17 (-4.96%)
BABA   91.19 (+0.39%)
AMD   95.54 (-4.53%)
MU   59.15 (-3.74%)
T   18.10 (+0.56%)
CGC   2.87 (-12.50%)
GE   74.93 (-0.33%)
F   15.19 (-3.74%)
DIS   108.13 (-0.90%)
AMC   22.45 (-6.30%)
PYPL   94.48 (-1.85%)
PFE   49.78 (+0.42%)
NFLX   229.94 (-1.52%)
S&P 500   4,122.47 (-0.42%)
DOW   32,774.41 (-0.18%)
QQQ   317.08 (-1.13%)
AAPL   164.92 (+0.03%)
MSFT   282.30 (+0.71%)
META   168.53 (-1.01%)
GOOGL   116.63 (-0.57%)
AMZN   137.83 (-1.13%)
TSLA   850.00 (-2.44%)
NVDA   170.86 (-3.97%)
NIO   19.17 (-4.96%)
BABA   91.19 (+0.39%)
AMD   95.54 (-4.53%)
MU   59.15 (-3.74%)
T   18.10 (+0.56%)
CGC   2.87 (-12.50%)
GE   74.93 (-0.33%)
F   15.19 (-3.74%)
DIS   108.13 (-0.90%)
AMC   22.45 (-6.30%)
PYPL   94.48 (-1.85%)
PFE   49.78 (+0.42%)
NFLX   229.94 (-1.52%)
S&P 500   4,122.47 (-0.42%)
DOW   32,774.41 (-0.18%)
QQQ   317.08 (-1.13%)
AAPL   164.92 (+0.03%)
MSFT   282.30 (+0.71%)
META   168.53 (-1.01%)
GOOGL   116.63 (-0.57%)
AMZN   137.83 (-1.13%)
TSLA   850.00 (-2.44%)
NVDA   170.86 (-3.97%)
NIO   19.17 (-4.96%)
BABA   91.19 (+0.39%)
AMD   95.54 (-4.53%)
MU   59.15 (-3.74%)
T   18.10 (+0.56%)
CGC   2.87 (-12.50%)
GE   74.93 (-0.33%)
F   15.19 (-3.74%)
DIS   108.13 (-0.90%)
AMC   22.45 (-6.30%)
PYPL   94.48 (-1.85%)
PFE   49.78 (+0.42%)
NFLX   229.94 (-1.52%)
NASDAQ:TXMD

TherapeuticsMD - TXMD Earnings Date, Estimates & Call Transcripts

$8.86
-0.38 (-4.11%)
(As of 08/9/2022 05:46 PM ET)
Add
Compare
Today's Range
$8.75
$9.23
50-Day Range
$4.72
$10.00
52-Week Range
$1.99
$47.95
Volume
107,122 shs
Average Volume
722,570 shs
Market Capitalization
$78.38 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$125.00

Earnings Summary

Upcoming
Earnings Date
Aug. 15Confirmed
Actual EPS
(May. 16)
-$4.72 Missed By -$1.22
Consensus EPS
(May. 16)
-$3.50
Last Year's Q2 EPS
(5/6/2021)
-$5.50
Skip Charts & View Estimated and Actual Earnings Data

TXMD Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

TXMD Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

TherapeuticsMD Analyst Forecasts

Current Year EPS Consensus Estimate: $-7.51 EPS
Next Year EPS Consensus Estimate: $-2.26 EPS

TXMD Earnings Date and Information

TherapeuticsMD last released its earnings results on May 16th, 2022. The reported ($4.72) earnings per share for the quarter, missing the consensus estimate of ($3.50) by $1.22. The company earned $19.33 million during the quarter, compared to analysts' expectations of $19.61 million. TherapeuticsMD has generated ($21.69) earnings per share over the last year (($21.69) diluted earnings per share). Earnings for TherapeuticsMD are expected to grow in the coming year, from ($7.51) to ($2.26) per share. TherapeuticsMD has confirmed that its next quarterly earnings report will be published on Monday, August 15th, 2022.

TherapeuticsMD Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/15/2022
(Confirmed)
 ($3.04)      
5/16/2022Q1 2022($3.50)($4.72)($1.22)($3.75)$19.61 million$19.33 million  
3/10/2022Q4 2021($3.00)($4.50)($1.50)($0.08)$30.07 million$18.68 million    
11/11/20219/30/2021($5.00)($5.50)($0.50)($0.11)$26.65 million$25.41 million    
8/4/20216/30/2021($5.50)($5.50)($0.11)$22.63 million$23.00 million    
5/6/20213/31/2021($5.00)($5.50)($0.50)($0.11)$20.22 million$19.87 million  
3/1/202112/31/2020($5.00)($7.50)($2.50)($0.15)$21.28 million$22.58 million  
11/9/20209/30/2020($7.00)($6.00)+$1.00($0.08)$17.67 million$19.34 million  
8/6/20206/30/2020($8.50)($9.50)($1.00)($0.15)$11.93 million$10.70 million  
5/6/20203/31/2020($9.50)($10.50)($1.00)($0.21)$11.48 million$12.25 million  
2/20/2020Q4 2019($10.00)($9.50)+$0.50($0.19)$12.82 million$15.90 million  
11/6/2019Q3($9.50)($6.50)+$3.00($0.13)$8.05 million$8.21 million  
8/6/2019Q2 2019($9.00)($9.50)($0.50)($0.15)$5.12 million$6.08 million  
5/6/20193/31/2019($8.50)($8.00)+$0.50($0.16)$5.96 million$3.95 million  
2/21/201912/31/2018($8.50)($8.50)($0.17)$5.03 million$5.09 million  
11/7/2018Q3($11.00)($8.00)+$3.00($0.16)$4.43 million$3.47 million  
7/30/2018Q2 2018($6.00)($7.65)($1.65)($0.15)$4.23 million$3.80 million
5/3/2018Q1 2018($5.00)($5.50)($0.50)($0.11)$4.18 million$3.77 million
2/20/2018Q4 2017($4.50)($5.00)($0.50)($0.10)$4.66 million$4.13 million  
11/6/2017Q3 2017($5.00)($3.55)+$1.45($0.07)$5.36 million$4.42 million
8/3/2017Q2 2017($5.50)($5.00)+$0.50($0.10)$4.91 million$4.25 million  
5/2/2017Q1 2017($5.50)($5.50)($0.11)$5.29 million$3.99 million
2/23/2017Q4 2016($6.00)($6.00)($0.12)$5.91 million$4.49 million  
11/3/2016Q3 2016($5.50)($6.50)($1.00)($0.13)$5.76 million$5.50 million
8/4/2016Q2 2016($5.00)($5.50)($0.50)($0.11)$5.63 million$4.40 million
5/3/2016Q1 2016($5.00)($5.50)($0.50)($0.11)$5.73 million$4.93 million
2/25/2016Q4 2015($5.00)($5.00)($0.10)$5.33 million$5.63 million  
11/4/2015Q3 2015($6.50)($5.50)+$1.00($0.11)$5.01 million$5.19 million
8/6/2015Q2 2015($6.00)($8.00)($2.00)($0.16)$4.65 million$4.80 million  
5/5/2015Q1 2015($5.00)($6.50)($1.50)($0.13)$4.34 million$4.48 million
3/10/2015Q4 2014($4.50)($5.00)($0.50)($0.10)$2.86 million$4.26 million
11/6/2014Q3 2014($3.50)($6.00)($2.50)($0.12)$3.90 million$4.19 million
8/6/2014Q2 2014($4.00)($3.50)+$0.50($0.07)$3.12 million$3.75 million
5/5/2014Q1 2014($3.00)($3.00)($0.06)$3.08 million$2.80 million
3/3/2014Q4 2013($3.00)($3.00)($0.06)$2.72 million$2.90 million
11/4/2013Q3 2013($2.00)($3.00)($1.00)($0.06)$2.55 million$2.30 million
8/6/2013Q2 2013($3.00)($2.50)+$0.50($0.05)$1.51 million$2.08 million
5/8/2013Q1 2013($3.00)($3.00)($0.06)$1.32 million$1.50 million  
3/12/2013Q4 2012($3.00)($2.50)+$0.50($0.05)
11/13/2012Q3 2012($2.00)($2.00)($0.04)












TherapeuticsMD Earnings - Frequently Asked Questions

When is TherapeuticsMD's earnings date?

TherapeuticsMD has confirmed that its next quarterly earnings data will be published on Monday, August 15th, 2022. Learn more on TXMD's earnings history.

Did TherapeuticsMD beat their earnings estimates last quarter?

In the previous quarter, TherapeuticsMD (NASDAQ:TXMD) missed the analysts' consensus estimate of ($3.50) by $1.22 with a reported earnings per share (EPS) of ($4.72). Learn more on analysts' earnings estimate vs. TXMD's actual earnings.

How can I listen to TherapeuticsMD's earnings conference call?

The conference call for TherapeuticsMD's latest earnings report can be listened to online. Listen to Conference Call

How much revenue does TherapeuticsMD generate each year?

TherapeuticsMD (NASDAQ:TXMD) has a recorded annual revenue of $86.95 million.

How much profit does TherapeuticsMD generate each year?

TherapeuticsMD (NASDAQ:TXMD) has a recorded net income of -$172.41 million. TXMD has generated -$21.69 earnings per share over the last four quarters.

What is TherapeuticsMD's EPS forecast for next year?

TherapeuticsMD's earnings are expected to grow from ($7.51) per share to ($2.26) per share in the next year.

More Earnings Resources from MarketBeat

Upcoming Earnings:
This page (NASDAQ:TXMD) was last updated on 8/9/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.